Two years of newborn screening for cystic fibrosis in North Macedonia: First experience
, , , , , , y
27 jul 2021
Acerca de este artículo
Categoría del artículo: Original Article
Publicado en línea: 27 jul 2021
Páginas: 41 - 46
DOI: https://doi.org/10.2478/bjmg-2021-0015
Palabras clave
© 2021 Fustik S, Anastasovska V, Plaseska-Karanfilska D, Stamatova A, Spirevska L, Pesevska M, Terzikj M, Vujovic M, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fustik, S
Department for Cystic Fibrosis, University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,”Skopje, Republic of North Macedonia
Anastasovska, V
Department for Neonatal Screening, University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,”Skopje, Republic of North Macedonia
Plaseska-Karanfilska, D
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov,” Macedonian Academy of Sciences and ArtsSkopje, Republic of North Macedonia
Stamatova, A
Department for Cystic Fibrosis, University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,”Skopje, Republic of North Macedonia
Spirevska, L
Department for Cystic Fibrosis, University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,”Skopje, Republic of North Macedonia
Pesevska, M
Department for Neonatal Screening, University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,”Skopje, Republic of North Macedonia
Terzikj, M
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov,” Macedonian Academy of Sciences and ArtsSkopje, Republic of North Macedonia
Vujovic, M
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov,” Macedonian Academy of Sciences and ArtsSkopje, Republic of North Macedonia